Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Clinical impact of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study

Abstract

Smoking is associated with a high risk for different diseases including respiratory tract infections in immunocompetent patients. However, data about the effects of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT) are limited. Therefore, we retrospectively investigated 608 patients aged ≥20 years with hematological disorders who received their first allo-HSCT at our group of hospitals between 2000 and 2015, and evaluated the impact of cigarette smoking before allo-HSCT on clinical outcomes by dividing patients into two groups according to the Brinkman index (BI) (nonsmokers or light smokers [BI: 0–500] and heavy smokers [BI: ≥ 500]). Multivariate analyses showed that heavy smoking was associated with a high 5-year cumulative incidence of chronic graft-versus-host disease (cGVHD) (hazard ratio [HR]: 1.73, 95% confidence interval [CI]: 1.15–2.61, p < 0.01). The 5-year overall survival (HR: 1.16, 95% CI: 0.86–1.58, p = 0.33) and disease-free survival (HR: 1.12, 95% CI: 0.83–1.52, p = 0.45) were similar between the two groups. Hence, cigarette smoking is correlated with cGVHD, although prospective studies must be conducted to further verify this result.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: PFT results at pretransplantation and 1 year post transplantation.
Fig. 2: Survival probability and cumulative incidence of relapse and GVHD.

Similar content being viewed by others

Data availability

The data supporting the results of this study are available from the corresponding author upon a reasonable request.

References

  1. Lucena CM, Torres A, Rovira M, Marcos MA, de la Bellacasa JP, Sánchez M, et al. Pulmonary complications in hematopoietic SCT: a prospective study. Bone Marrow Transplant. 2014;49:1293–9.

    Article  CAS  Google Scholar 

  2. Afessa B, Peters SG. Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med. 2006;27:297–309.

    Article  Google Scholar 

  3. Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A, et al. The effect of smoking on allogeneic transplant outcomes. Biol Blood Marrow Transplant. 2009;15:1277–87.

    Article  CAS  Google Scholar 

  4. Ehlers SL, Gastineau DA, Patten CA, Decker PA, Rausch SM, Cerhan JR, et al. The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia. Bone Marrow Transplant. 2011;46:285–90.

    Article  CAS  Google Scholar 

  5. Chang G, Orav EJ, McNamara T, Tong MY, Antin JH. Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome. Cancer. 2004;101:782–9.

    Article  Google Scholar 

  6. Tran BT, Halperin A, Chien JW. Cigarette smoking and outcomes after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:1004–11.

    Article  CAS  Google Scholar 

  7. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, Breiman RF. Active Bacterial Core Surveillance Team. Cigarette smoking and invasive pneumococcal disease. N Engl J Med. 2000;342:681–9.

    Article  CAS  Google Scholar 

  8. Chelghoum Y, Danaïla C, Belhabri A, Charrin C, Le QH, Michallet M, et al. Influence of cigarette smoking on the presentation and course of acute myeloid leukemia. Ann Oncol. 2002;13:1621–7.

    Article  CAS  Google Scholar 

  9. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328:159–63.

    Article  CAS  Google Scholar 

  10. Ford MB, Sigurdson AJ, Petrulis ES, Ng CS, Kemp B, Cooksley C, et al. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer. 2003;98:1457–64.

    Article  Google Scholar 

  11. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomark Prev. 2005;14:2287–93.

    Article  CAS  Google Scholar 

  12. Pickles T, Liu M, Berthelet E, Kim-Sing C, Kwan W, Tyldesley S. PROSTATE COHORT OUTCOMES INITIATIVE. The effect of smoking on outcome following external radiation for localized prostate cancer. J Urol. 2004;171:1543–6.

    Article  CAS  Google Scholar 

  13. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2009;15:367–9.

    Article  Google Scholar 

  14. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. Consens conference on acute GVHD grading. Bone Marrow Transplant. 1994;1995:825–8.

    Google Scholar 

  15. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204–17.

    Article  CAS  Google Scholar 

  16. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

    Article  CAS  Google Scholar 

  17. Rigotti NA. Clinical practice. Treatment of tobacco use and dependence. N Engl J Med. 2002;346:506–12.

    Article  Google Scholar 

  18. Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7:223–9.

    Article  CAS  Google Scholar 

  19. Savani BN, Montero A, Wu C, Nlonda N, Read E, Dunbar C, et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:223–30.

    Article  Google Scholar 

  20. Allen JL, Fore MS, Wooten J, Roehrs PA, Bhuiya NS, Hoffert T, et al. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. Blood. 2012;120:2529–36.

    Article  CAS  Google Scholar 

  21. Morissette MC, Gao Y, Shen P, Thayaparan D, Bérubé JC, Paré PD, et al. Role of BAFF in pulmonary autoantibody responses induced by chronic cigarette smoke exposure in mice. Physiol Rep. 2016;4:e13057.

    Article  Google Scholar 

  22. Polverino F, Baraldo S, Bazzan E, Agostini S, Turato G, Lunardi F, et al. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family. Am J Respir Crit Care Med. 2010;182:1011–9.

    Article  Google Scholar 

  23. Savani BN, Montero A, Srinivasan R, Singh A, Shenoy A, Mielke S, et al. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. Biol Blood Marrow Transplant. 2006;12:1261–9.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank the medical staff at the Yokohama City University Medical Center, Yokohama City University School of Medicine, and Kanagawa Cancer Center for their excellent patient care.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

We gratefully acknowledge the contributions of all co-authors for data collection and analysis support. All authors critically revised the report, commented on drafts of the manuscript, and approved the final report.

Corresponding author

Correspondence to Shin Fujisawa.

Ethics declarations

Competing interests

TT received personal fees from Otsuka, Novartis, Pfizer, BMS, Daiichi Sankyo, and Astellas, outside the submitted study. SF received research funding from Takeda Pharmaceutical and Otsuka Pharmaceutical. HN received research funding from Daiichi-Sankyo, Chugai Pharmaceuticals, Astellas, Asahikasei pharma, Takeda pharmaceuticals, Pfizer and Eizai, honoraria from Novartis and Daiichi Sankyo.

Ethical approval

This study was performed in accordance with the Declaration of Helsinki and the Ethics Guidelines for Clinical Research published by the Ministry of Health, Labor, and Welfare of Japan. This retrospective study was approved by Ethical Committee for Medical and Biological Research Involving Human Subjects of Yokohama City University Medical Center (B180800006). Approval for the protocol and written informed consent forms were obtained from the ethics committees at each institution. The written decision can be presented upon request.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ohashi, T., Aoki, J., Ando, T. et al. Clinical impact of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study. Bone Marrow Transplant 57, 1124–1132 (2022). https://doi.org/10.1038/s41409-022-01678-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41409-022-01678-7

This article is cited by

Search

Quick links